These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1952268

  • 41. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
    Kriessmann A, Neiss A.
    Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
    [No Abstract] [Full Text] [Related]

  • 42. Micro- and macrocirculatory, and biohumoral changes after a month of physical exercise in patients with intermittent claudication.
    Pancera P, Prior M, Zannoni M, Lucchese L, De Marchi S, Arosio E.
    Scand J Rehabil Med; 1995 Jun; 27(2):73-6. PubMed ID: 7569823
    [Abstract] [Full Text] [Related]

  • 43. Muscle perfusion with technetium-MIBI in lower extremity peripheral arterial diseases.
    Sayman HB, Urgancioglu I.
    J Nucl Med; 1991 Sep; 32(9):1700-3. PubMed ID: 1880572
    [Abstract] [Full Text] [Related]

  • 44. Effects of physical training on peripheral vascular disease: a controlled study.
    Mannarino E, Pasqualini L, Menna M, Maragoni G, Orlandi U.
    Angiology; 1989 Jan; 40(1):5-10. PubMed ID: 2642671
    [Abstract] [Full Text] [Related]

  • 45. Hemorrheological, micro- and macrocirculatory effects of naftidrofuryl in an acute study: a randomized, placebo-controlled, double-blind individual comparison.
    Jung F, Kiesewetter H, Mrowietz C, Leipnitz G, Braun B, Wappler M, Scheffler P, Wenzel E.
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):507-14. PubMed ID: 3679623
    [Abstract] [Full Text] [Related]

  • 46. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 47. Comparison of standard one-minute treadmill exercise and strandness test (absolute walking distance) in relation to site of lesion, walking distance, and diastolic blood flow velocity (Doppler curves).
    Fabry R, Dubost JJ, Pochon P, Duchêne-Marullaz P.
    Angiology; 1990 Oct; 41(10):869-76. PubMed ID: 2221465
    [Abstract] [Full Text] [Related]

  • 48. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J, Kieser M, Hölscher U.
    Vasa; 1996 Oct; 25(3):265-74. PubMed ID: 8967154
    [Abstract] [Full Text] [Related]

  • 49. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
    Testart J, Guidicelli H, Glanddier G, Mosnier M.
    Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):542-7. PubMed ID: 7864561
    [Abstract] [Full Text] [Related]

  • 50. Treatment of intermittent claudication: two different mechanisms.
    Linhart J, Vanĕk I.
    Int Angiol; 1991 Nov; 10(1):6-9. PubMed ID: 2071977
    [Abstract] [Full Text] [Related]

  • 51. A comparison between the ankle systolic pressure and mercury strain gauge plethysmography in the assessment of patients with arterial disease of the lower limbs.
    Steer HW, Fletcher EW, Morris PJ.
    Surgery; 1980 Nov; 88(5):636-41. PubMed ID: 7434203
    [Abstract] [Full Text] [Related]

  • 52. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G, Böhme H, Heidrich H, Heinrich F, Hirche H, Maass U, Mörl H, Rudofsky G.
    Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
    [Abstract] [Full Text] [Related]

  • 53. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
    Pointel JP, Thomas C, Mosnier M, Percebois G, Debry G.
    Angiology; 1986 Sep; 37(9):647-53. PubMed ID: 3767072
    [Abstract] [Full Text] [Related]

  • 54. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
    D'Hooge D, Lehert P, Clement DL.
    Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
    [Abstract] [Full Text] [Related]

  • 55. Exercise capacity and Doppler pressure measurements in symptomatic peripheral arterial obstructive disease.
    Leder U, Saul T, Frankenstein L, Krack A, Baer H, Poehlmann G, Figulla HR.
    Vasa; 2002 May; 31(2):107-10. PubMed ID: 12099140
    [Abstract] [Full Text] [Related]

  • 56. Oxygen uptake kinetics during exercise in chronic heart failure: influence of peripheral vascular reserve.
    Hepple RT, Liu PP, Plyley MJ, Goodman JM.
    Clin Sci (Lond); 1999 Nov; 97(5):569-77. PubMed ID: 10545307
    [Abstract] [Full Text] [Related]

  • 57. The effect of naftidrofuryl on intermittent claudication: a meta-analysis.
    Lehert P, Riphagen FE, Gamand S.
    J Cardiovasc Pharmacol; 1990 Nov; 16 Suppl 3():S81-6. PubMed ID: 1369727
    [Abstract] [Full Text] [Related]

  • 58. [Effect of naftidrofuryl on the ischemia model in healthy probands].
    Rudofsky G.
    Vasa; 1988 Nov; 17(3):199-207. PubMed ID: 3051762
    [No Abstract] [Full Text] [Related]

  • 59. Effect of femoral profundaplasty on blood flow.
    Wright CJ.
    Can J Surg; 1983 Jul; 26(4):325-7. PubMed ID: 6861022
    [Abstract] [Full Text] [Related]

  • 60. The effect of active training on the nutritive blood flow in exercising ischemic legs.
    Zetterquist S.
    Scand J Clin Lab Invest; 1970 Jan; 25(1):101-11. PubMed ID: 5444955
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.